Clinical Trial Update: Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) [Phase 2]

View source ↗

Summary

This clinical trial update reports the results of a Phase 2 proof-of-concept study evaluating efficacy and safety in Parkinson's disease patients with end-of-do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED